Embryo genome sequencing for IVF

GenEmbryomics is the only company to offer a comprehensive whole-genome sequencing screening test for your IVF embryos.

Order GenomeScreen™ through your IVF provider.

*For Research Use Only.

Every family wants their children to be happy and healthy

We provide actionable whole genome sequencing and
interpretation of your embryos genomes so that you
make informed decisions for the future of your family

Advantages of whole genome sequencing for your IVF cycle

Embryo genome screening coverage

SNPs, insertions & deletions, copy number variations, mosaicism and chromosome aneuploidies

Parent to child screening

We screen transmitted variants from the embryos parents with an accuracy of >99.9%

De novo
mutations

New mutations introduced at fertilisation are detected and graded for screening (>95.1% accuracy)

Step 1

Whole-genome screening with GenomeScreen™ in the GenEmbryomics patient portal will allow you to provide your doctors information who can arrange for DNA sample collection.

Step 2

The embryos genome sequence is analysed to determine if they carry any damaging mutations that may be threatening their health.

Step 3

The GenomeScreen™ report is a summary of all the genetic data related to disease, and it offers guidance for the future health of your embryos.

Expert opinion

Testing for all known genetic conditions can give couples more information and choices, in turn reducing their chance of having a child with a seriously debilitating, life-limiting genetic condition.

Prof. David Amor
PhD University of Melbourne

This is a profoundly exciting discovery in assistive reproductive technology that has far reaching implications for couples looking for answers to the reason for their subfertility and their child’s health.

Santiago Munne PhD
Overture Life Inc.

Whole genome sequencing of IVF embryos with GenEmbryomics’ Panacea GenomeScreen™ is the most advanced IVF embryo laboratory test ever developed”

Nick Murphy PhD
PhD Monash Univerity

Testing for all known genetic conditions can give couples more information and choices, in turn reducing their chance of having a child with a seriously debilitating, life-limiting genetic condition.

Prof. David Amor
PhD University of Melbourne

This is a profoundly exciting discovery in assistive reproductive technology that has far reaching implications for couples looking for answers to the reason for their subfertity and their child’s health.

Santiago Munne PhD
Overture Life Inc.

Whole genome sequencing of IVF embryos with GenEmbryomics’ Panacea GenomeScreen™ is the most advanced IVF embryo laboratory test ever developed”

Nick Murphy PhD
PhD Monash Univerity
Want more information?

Please submit the form to get more information about how we can be helpful

Send us a message and we’ll respond as soon as possible.